Your browser is no longer supported. Please, upgrade your browser.
Settings
LABU Direxion Daily S&P Biotech Bull 3X ETF daily Stock Chart
LABU [NYSE]
Direxion Daily S&P Biotech Bull 3X ETF
Index- P/E- EPS (ttm)- Insider Own- Shs Outstand- Perf Week-3.61%
Market Cap- Forward P/E- EPS next Y- Insider Trans- Shs Float- Perf Month3.28%
Income- PEG- EPS next Q- Inst Own- Short Float- Perf Quarter10.66%
Sales- P/S- EPS this Y- Inst Trans- Short Ratio0.60 Perf Half Y75.34%
Book/sh- P/B- EPS next Y- ROA- Target Price- Perf Year133.07%
Cash/sh- P/C- EPS next 5Y- ROE- 52W Range24.44 - 92.56 Perf YTD163.14%
Dividend- P/FCF- EPS past 5Y- ROI- 52W High-10.99% Beta-
Dividend %- Quick Ratio- Sales past 5Y- Gross Margin- 52W Low237.11% ATR3.54
Employees- Current Ratio- Sales Q/Q- Oper. Margin- RSI (14)51.26 Volatility5.01% 4.35%
OptionableYes Debt/Eq- EPS Q/Q- Profit Margin- Rel Volume0.64 Prev Close82.64
ShortableYes LT Debt/Eq- Earnings- Payout- Avg Volume1.16M Price82.39
Recom- SMA20-3.59% SMA508.17% SMA20043.66% Volume745,175 Change-0.30%
Oct-20-17 03:16PM  Starting Small Offers Some Protection With Opportunities Investor's Business Daily
Sep-15-17 03:26PM  Biotech, Pharma ETFs Leave Pricing Drama Behind ETF Trends
Sep-08-17 10:31AM  Biotech ETF Investing is Hot, Can Get Hotter ETF Trends
Sep-01-17 10:49AM  Biotech ETFs Remain Bell of the Ball ETF Trends
Aug-31-17 04:37PM  A Sign Of Things To Come? Traders Are Betting On More Biotech Mergers Benzinga +8.56%
Aug-30-17 10:53AM  Biotech ETF Investing is Starting to Look Good Heres Why ETF Trends
Jul-27-17 02:43PM  4 Things To Know Before Trading A Leveraged ETF Benzinga -7.85%
Jul-03-17 09:30AM  The Zacks Analyst Blog Highlights: Direxion Daily S&P Biotech Bull 3X ETF, Direxion Daily South Korea Bull 3X ETF, Direxion Daily CSI China Internet Bull 2X Shares, Direxion Daily Hmbldrsls Bull 3X ETF and Direxion Daily MSCI India Bull 3 Zacks
Jun-30-17 02:40PM  Cure The Summer Doldrums With Leveraged Biotech ETFs Benzinga
11:41AM  Best Leveraged ETFs of First Half of 2017 Zacks
Jun-23-17 02:43PM  Too Late To Catch Biotech Rally As Trump Fears Subside? Investor's Business Daily
May-18-17 01:08PM  Are Stock Returns during Summer Months That Bad? Market Realist +6.48%
Apr-04-17 09:02AM  Healthcare Moves Have Been Muted, but Could We Get a Surprise? Market Realist
09:02AM  Healthcare Moves Have Been Muted, but Could We Get a Surprise?
Mar-20-17 12:46PM  Biotech firm says its closing in on the cancer that killed Steve Jobs MarketWatch
12:46PM  Biotech firm says its closing in on the cancer that killed Steve Jobs at MarketWatch
Feb-26-17 08:26PM  Zacks Podcast Highlights: How Do Leveraged and Inverse ETFs Work? Zacks
08:26PM  Zacks Podcast Highlights: How Do Leveraged and Inverse ETFs Work?
Feb-17-17 01:40PM  Biotech 2017: 4 Ideas for A Stockpicker's Year Barrons.com
01:40PM  Biotech 2017: 4 Ideas for A Stockpicker's Year at Barrons.com
Jan-31-17 05:09PM  Stock Market Roundup Jan. 31: Nasdaq Rebounds Amid Trump Biotech Meeting Zacks +12.28%
05:09PM  Stock Market Roundup Jan. 31: Nasdaq Rebounds Amid Trump Biotech Meeting
01:08PM  Biotech Stocks Gain on Latest Trump Drug Price Statements Zacks
01:08PM  Biotech Stocks Gain on Latest Trump Drug Price Statements
Jan-11-17 12:31PM  Stocks Recover But Pharma Still Down After Trump's Threats Forbes -10.63%
12:31PM  Stocks Recover But Pharma Still Down After Trump's Threats at Forbes
Jan-04-17 10:56AM  Trying to Knock Out Some Individual Trades, but it Is not Easy TheStreet.com +13.41%
10:56AM  Trying to Knock Out Some Individual Trades, but it Is not Easy
Dec-08-16 10:34AM  How Will Trumps Take on the ACA Affect Healthcare Stocks? Market Realist
10:34AM  How Will Trumps Take on the ACA Affect Healthcare Stocks?
Nov-15-16 10:47AM  6 Leveraged ETFs Soaring on Trump Rally Zacks
10:47AM  6 Leveraged ETFs Soaring on Trump Rally
Nov-11-16 03:16PM  Biotech ETFs Unwind Political Risk After Trump Victory
Nov-08-16 09:34AM  Which Sectors to Invest in If Donald Trump Wins
Nov-01-16 11:20AM  Biotech Stocks Rise As Most Other Sectors Fall
Oct-21-16 09:54AM  Five Biotech ETFs Posting Strong Second-Halfs: From ALPS Medical Breakthroughs (SBIO) To The SPDR S&P Biotech ETF (XBI) Insider Monkey
09:54AM  Five Biotech ETFs Posting Strong Second-Halfs: From ALPS Medical Breakthroughs (SBIO) To The SPDR S&P Biotech ETF (XBI) at Insider Monkey
Oct-14-16 03:26PM  Can Biotech Stocks Stay Trendy? -8.90%
11:43AM  Seize ETF Tools To Position Your Portfolio For Any Election Outcome
Oct-04-16 12:15AM  Best and Worst Performing ETFs of Q3 2016 (SOXL, LABU) at Investopedia
Oct-03-16 10:58AM  5 Best Performing Leveraged ETFs of September
Sep-27-16 03:21PM  Loving LABU: A Leveraged Biotech ETF On A Torrid Pace
Aug-25-16 06:52AM  The Active Traders Guide To Hillary Clinton's Rhetoric
Aug-24-16 04:22PM  Ugly Underlying Action Should Stay Hidden -12.93%
Aug-08-16 05:09PM  How Volatility Affects 2 Popular Leveraged ETFs -5.76%
Aug-04-16 01:46PM  Biotech Rally Stokes Activity In Leveraged ETFs
Jul-19-16 02:39PM  Hot Spots Short-Term ETF Traders Are Targeting -5.45%
Jun-22-16 02:07PM  Traders Get It Right (Sort Of) With Leveraged Biotech ETFs
Jun-10-16 09:21AM  A Conservative Way To Short The S&P 500 -6.47%
Jun-07-16 12:33AM  Biotech Bounce: Sizzle Or Fizzle? -5.38%
May-27-16 01:11PM  This Biotech ETF Could Be Ready To Party
May-04-16 09:21PM  BIB vs. LABU: Comparing Leveraged Biotech ETFs at Investopedia -11.92%
Apr-19-16 07:10AM  Return Of The Mack: This Biotech ETF Is Back -5.66%
Apr-07-16 12:30PM  A Leader-Laggard Long-Short ETF Pair Trade
Apr-06-16 08:15AM  Inklings Of Upside For A Leveraged Biotech ETF +22.46%
Mar-22-16 05:00PM  Reminder: Direxion Announces Reverse and Forward Share Splits of Ten Leveraged ETFs PR Newswire +9.75%
Mar-08-16 09:00AM  Trader's Notebook: Is It Time to Short Netflix and Facebook? -15.87%
Mar-02-16 10:35AM  This Market Is 'Climbing the Wall of Worry' +12.44%
Feb-19-16 06:11PM  Direxion Announces Reverse and Forward Share Splits of Ten Leveraged ETFs PR Newswire
08:50AM  Some Traders Aren't Shy About Betting On A Biotech Rebound
Feb-04-16 10:48AM  Big Caps Signal a Rotation Taking Place +5.82%
Jan-22-16 07:11AM  Even With Volatility, Investors Love Biotech ETFs +8.64%
Jan-12-16 07:20AM  Betting On A Biotech Bounce With A Familiar ETF +8.84%
Dec-23-15 05:46AM  LABU: Direxion Daily S&P Biotech Bull 3X ETF at Investopedia
Dec-01-15 07:40AM  Another Visit With A Leveraged Biotech ETF
Oct-28-15 03:12PM  Traders Get Adventurous With Leveraged Biotech ETFs +8.14%
02:22PM  Is There A Bubble In Leveraged ETFs? at Barrons.com
Oct-24-15 05:37PM  Volatility Sparks Inflows To Inverse, Leveraged ETFs
Oct-02-15 02:53PM  Breaking Down Biotech ETFs With Leverage
Sep-28-15 04:58PM  Capitulation In Biotech? ETF Suffers Biggest One-Day Drop Since 2011 at Barrons.com
03:57PM  Wild Ride For Leveraged Biotech ETFs Continues
Sep-25-15 12:08PM  Guide to Inverse & Leveraged Biotech ETF Investing
Sep-24-15 02:57PM  The 3 Key Factors in Biotech ETF Investing
Sep-23-15 10:48AM  Traders Bet Against Hillary With Leveraged Biotech ETF
Sep-22-15 02:34PM  Investors In This Biotech ETF Must Have Loved Hillary Clinton's Tweet
Sep-16-15 07:18AM  They're Heeere: Leveraged Cybersecurity ETFs
Aug-20-15 03:28PM  A Bad Sign For Biotech Bulls
Aug-19-15 01:20PM  4 New Leveraged ETFs Right For The Times
Aug-07-15 02:31PM  A Bad Week For Biotech Was Great For This ETF
Jul-15-15 08:20AM  Traders Bet on new Leveraged Biotech ETFs
Jun-23-15 12:30PM  More Triple-Leveraged Biotech ETFs Come to Town
09:00AM  Mess With the Leveraged Biotech Bull ETF and get the Horns
Jun-09-15 12:08PM  Intro Guide to Leveraged Biotech ETF Investing - ETF News And Commentary
Jun-05-15 12:53PM  Preparing for Biotech ETF Retrenchment
Jun-02-15 08:00AM  New Leveraged Biotech ETF off to a Fast Start
May-28-15 11:47AM  Back in the Lab: Triple-Leveraged Biotech ETFs are Here
08:30AM  Direxion Investments Launches Four Leveraged ETFs for Active Traders PR Newswire
The investment seeks daily investment results, before fees and expenses, of 300% of the daily performance of the S&P Biotechnology Select Industry Index ("index"). The fund, under normal circumstances, invests at least 80% of its net assets (plus borrowing for investment purposes) in financial instruments that provide daily leveraged exposure to the index and/or exchange-traded funds ("ETFs") that track the index. The index is designed to measure the performance of the biotechnology sub-industry based on the Global Industry Classification Standards ("GICS"). The fund is non-diversified.